Prevention of blood clots; treatment of deep vein thrombosis (DVT) and pulmonary embolism
Recommended For
Patients at risk of blood clots or undergoing surgery
Dosage
60 mg per dose
Dosage Guidelines
Administered subcutaneously as directed by a healthcare provider
Suitable For
Adults
Quantity
1 vial
Storage Instructions
Store at 2-8C and protect from light; do not freeze
About LMWX-60 MG
The LMWX-60 MG is an injection medication containing Enoxaparin Sodium, primarily used for the prevention of blood clots and treatment of conditions such as deep vein thrombosis (DVT) and pulmonary embolism. It is a suitable anti-inflammatory drug for adults at risk of blood clots or those undergoing surgery. Each box comes with 10 vials, with each vial containing 60 mg of Enoxaparin Sodium to be administered subcutaneously following healthcare provider instructions. The medication should be stored between 2-8C, shielded from light, and should not be frozen. Derived synthetically, this drug provides effective dosage and guidelines for patient safety and treatment.
FAQs of LMWX-60 MG:
Q: What is the primary function of LMWX-60 MG?
A: The primary function of LMWX-60 MG is the prevention of blood clots and the treatment of deep vein thrombosis (DVT) and pulmonary embolism.
Q: What is the recommended dosage of LMWX-60 MG?
A: The recommended dosage of LMWX-60 MG is 60 mg per dose, to be administered subcutaneously as directed by a healthcare provider.
Q: How should LMWX-60 MG be stored?
A: LMWX-60 MG should be stored at temperatures between 2-8C, protected from light, and should not be frozen.
Q: Who is LMWX-60 MG suitable for?
A: LMWX-60 MG is suitable for adults at risk of blood clots or those undergoing surgery.
Q: How many vials are included in each box of LMWX-60 MG?